Showing 1 - 10 of 73
) provided to Research and Innovation (R&I) in partner countries during the last EU budget period (2007-2013). …
Persistent link: https://www.econbiz.de/10011624959
Persistent link: https://www.econbiz.de/10009639656
Persistent link: https://www.econbiz.de/10009639743
Persistent link: https://www.econbiz.de/10009639747
Persistent link: https://www.econbiz.de/10009639787
Persistent link: https://www.econbiz.de/10009640850
This paper provides a comparative assessment of the draft “Regulation on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems” as proposed by the European Commission in October 2004. The Regulation...
Persistent link: https://www.econbiz.de/10009638104
The workshop addressed a variety of issues, including the magnitude of the pharmaceuticals market and the amounts of pharmaceutically active substances produced; the pathways by which active substances enter the environment; detected or assumed environmental effects; and ways to reduce impacts....
Persistent link: https://www.econbiz.de/10009640781
Persistent link: https://www.econbiz.de/10009640861
) exports. The sector supplies products to almost all downstream industry sectors and is an important engine for innovation for …
Persistent link: https://www.econbiz.de/10010254594